PRIMARY USE : for chronic hepatitis C viral infection (HCV)

Introduction :

Daclatasvir is distinguished as a first non structural viral protein NS5A inhibitor. It is a phosphoprotein that acts as leading role in hepatitis C multiplication.

The action produced by Daclatasvir, which inhibits the NS5A replication complex is not clearly known. But it is conclude that Daclatasvir prohibits viral RNA multiplication.

Indication :

Daclatasvir an anti viral medication, used to treat hepatitis C virus from replicating in the body. It is also used to treat genotype III chronic hepatitis C virus (HCV) in adolescent without cirrhosis.

Daclatasvir not used separately, it should be combined with Sofosbuvir. Daclahep Tablet is used in combination form only, with other anti viral medications such as Sofosbuvir, interferon and ribavirin for the treatment of hepatitis C infection.

Usual dosage of Daclahep :

Commonly Daclatasvir is used in adolescents, usual dose is 60mg which is taken as orally at once daily for the period of 12 weeks.

Possible side effects:


• Headache
• Dizziness
• Migraine
• Somnolence

Skin problems :

• Erythema, Pruritus, rash, dry skin,
• alopecia and Erythema multiforme

Mental disorder :

• Insomnia, irritability
• Depression, anxiety

Blood related problems :

• Anemia, neutropenia
• Thrombocytopenia
• decreased hemoglobin
• Eosinophilia

Pulmonary disorders :

• Cough
• Nasopharyngitis
• dyspnea
• Exertional dyspnea
• nasal congestion
• upper respiratory tract infection

Musculoskeletal :

• Myalgia
• arthralgia
• Back pain


• Diarrhea, nausea
• Upper abdominal pain
• abdominal pain
• constipation, flatulence,gastro
• esophageal reflux disease
• dry mouth, vomiting
• elevated lipase

Digestive problems :

Decreased appetite

Ocular :

Dry eye

Cardiovascular :

• Symptomatic bradycardia
• heart block
• cardiac arrhythmias

Liver problems :

• Increased ALT
• increased AST
• increased total bilirubin
• Hepatitis B reactivation


Signs of an allergic reactions: hives;

Difficult breathing;
Swelling of face lips, tongue, or throat.

Patient receiving both Daclatasvir with Sofosbuvir, they also take a amiodarone: These combination of medicines can cause fatal side effects on your heart.

Very slow heartbeats;
Chest pain,
Shortness of breath; or
a light-headed feeling, like you might pass out.

Confusion, memory problems; severe dizziness; weakness, tiredness; or general ill feeling.

Before going to start the treatment, if patient having the following conditions they must seek medical advice :

• liver problems and/or liver transplant heart problems
• taking any other prescription or non-prescription medicines
• pregnant or your partner is pregnant
• trying to become pregnant or your partner is trying to become pregnant
• Breastfeeding or planning to breastfeed

Precautions :

Caution should be taken while using Daclatasvir in patient having liver problems and any allergic conditions.

Pregnancy and lactation :

Usage of Daclatasvir in both pregnancy and lactation has not been established


Stored at 25°C (77°F); container should be stored between 15°C and 30°C (59°F and 86°F).

Call To Million health pharmaceuticals

Million health pharmaceuticals has an established history of contract manufacturing Tablets, Capsules,Injections .Ointments,Syrups,Dry Syrups etc, of sterile formulations for the various pharmaceutical and biotechnology companies. From large organizations to small, Million health pharmaceuticals can accommodate a wide range of manufacturing needs.


Million Health Pharmaceuticals

Million Health Pharmaceuticals can produce sterile products in vial sizes ranging from 1ml to 100ml. Million health pharmaceuticals can also produce sterile formulations in prefilled syringes, bags, or bottle format.

Portion 'A' First Floor,
Old No. 131, New No. 50,
Pedariyar Koil Street,
Seven Wells,
Chennai - 600001.



Your message has been sent. Thank you!


This information should not be used to decide whether or not to take this Product or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this Product . It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using this product.